AmbioGen AB

Active
559453-4157Limited company (AB)Registered 2023SOLNA

Key figures

4 791 000 kr+102,1%
Revenue 2025
+102,1%
Average annual growth 2024–2025
02 m4 m6 m20242025

Key figures

2025

Summary: AmbioGen AB

What kind of company is it?

AmbioGen AB (org. no. 559453-4157) is a limited company (AB). The company was registered in 2023 and has existed for 3 years. Registered seat: Solna. Industry according to Statistics Sweden: research and experimental development on biotechnology (SNI 72101).

How is the company doing financially?

Net sales in financial year 2025 were 4 791 000 kr, up 102 % on the previous year (2 371 000 kr). Net profit for 2025 was 1 353 923 kr (28,3 % of net sales). Employees in financial year 2025: 4 (previous year: 1). Net sales per employee were 1 197 750 kr. At the end of financial year 2025, total assets were 3 157 678 kr and equity 2 353 023 kr (equity ratio 74,5 %).

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Summary of annual reports2024–2025
20242025
Sales revenue2 371 0004 791 000
Profit for the reporting year974 1001 353 923
Retained earnings of previous periods——
Total assets2 905 6213 157 678
Total liabilities1 906 521804 655
Total equity999 1002 353 023
Employees14

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.